---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-154062"
form_type: "8-K"
ticker: "NKTR"
cik: "0000906709"
company_name: "NEKTAR THERAPEUTICS"
filed_at: "2025-07-01T23:59:59+00:00"
generated_at: "2026-05-18T11:45:31.180342+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Nektar Therapeutics prices $100M public offering at $23.50 per share

## Summary
- Nektar prices 4,255,320 shares at $23.50/share for gross proceeds of $100M.
- Net proceeds estimated at $93.7M ($107.8M if underwriters' option exercised in full).
- Offering expected to close July 2, 2025; Jefferies and Piper Sandler are joint bookrunners.
- Proceeds to fund R&D, clinical development, manufacturing, and other general corporate purposes.
- Underwriters have a 30-day option to purchase up to an additional 638,298 shares.

## SEC filing metadata
- accession: 0001193125-25-154062
- form_type: 8-K
- ticker: NKTR
- cik: 0000906709
- company_name: NEKTAR THERAPEUTICS
- filed_at: 2025-07-01T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/906709/000119312525154062/0001193125-25-154062-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/906709/000119312525154062/d943939d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-154062
- JSON: https://secwatch.observer/filing/0001193125-25-154062.json
- Plain text: https://secwatch.observer/filing/0001193125-25-154062.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.